Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Identifieur interne : 003880 ( Main/Exploration ); précédent : 003879; suivant : 003881Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Auteurs : Aikou Okamoto [Canada] ; Rosalind M. Glasspool ; Seiji Mabuchi ; Noriomi Matsumura ; Hiroyuki Nomura ; Hiroaki Itamochi ; Masashi Takano ; Tadao Takano ; Nobuyuki Susumu ; Daisuke Aoki ; Ikuo Konishi ; Alan Covens ; Jonathan Ledermann ; Delia Mezzanzanica ; Delia Mezzazanica ; Christopher Steer ; David Millan ; Iain A. Mcneish ; Jacobus Pfisterer ; Sokbom Kang ; Laurence Gladieff ; Jane Bryce ; Amit OzaSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.
Descripteurs français
- KwdFr :
- Adénocarcinome à cellules claires (), Adénocarcinome à cellules claires (anatomopathologie), Association thérapeutique, Consensus, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Oncologie médicale, Sociétés médicales, Tumeurs de l'ovaire (), Tumeurs de l'ovaire (anatomopathologie).
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer with a distinct clinical behavior. There are marked geographic differences in the prevalence of CCC. The CCC is more likely to be detected at an early stage than high-grade serous cancers, and when confined within the ovary, the prognosis is good. However, advanced disease is associated with a very poor prognosis and resistance to standard treatment. Cytoreductive surgery should be performed for patients with stage II, III, or IV disease. An international phase III study to compare irinotecan/cisplatin and paclitaxel/carboplatin as adjuvant chemotherapy for stage IIV CCC has completed enrollment (GCIG/JGOG3017). Considering the frequent PIK3CA mutation in CCC, dual inhibitors targeting PI3K, AKT in the mTOR pathway, are promising. Performing these trials and generating the evidence will require considerable international collaboration.
DOI: 10.1097/IGC.0000000000000289
PubMed: 25341576
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003342
- to stream PubMed, to step Curation: 003231
- to stream PubMed, to step Checkpoint: 003231
- to stream Ncbi, to step Merge: 001F27
- to stream Ncbi, to step Curation: 001F27
- to stream Ncbi, to step Checkpoint: 001F27
- to stream Main, to step Merge: 003915
- to stream Main, to step Curation: 003880
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.</title><author><name sortKey="Okamoto, Aikou" sort="Okamoto, Aikou" uniqKey="Okamoto A" first="Aikou" last="Okamoto">Aikou Okamoto</name><affiliation wicri:level="1"><nlm:affiliation>*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto</wicri:regionArea><wicri:noRegion>Toronto</wicri:noRegion></affiliation></author><author><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name></author><author><name sortKey="Mabuchi, Seiji" sort="Mabuchi, Seiji" uniqKey="Mabuchi S" first="Seiji" last="Mabuchi">Seiji Mabuchi</name></author><author><name sortKey="Matsumura, Noriomi" sort="Matsumura, Noriomi" uniqKey="Matsumura N" first="Noriomi" last="Matsumura">Noriomi Matsumura</name></author><author><name sortKey="Nomura, Hiroyuki" sort="Nomura, Hiroyuki" uniqKey="Nomura H" first="Hiroyuki" last="Nomura">Hiroyuki Nomura</name></author><author><name sortKey="Itamochi, Hiroaki" sort="Itamochi, Hiroaki" uniqKey="Itamochi H" first="Hiroaki" last="Itamochi">Hiroaki Itamochi</name></author><author><name sortKey="Takano, Masashi" sort="Takano, Masashi" uniqKey="Takano M" first="Masashi" last="Takano">Masashi Takano</name></author><author><name sortKey="Takano, Tadao" sort="Takano, Tadao" uniqKey="Takano T" first="Tadao" last="Takano">Tadao Takano</name></author><author><name sortKey="Susumu, Nobuyuki" sort="Susumu, Nobuyuki" uniqKey="Susumu N" first="Nobuyuki" last="Susumu">Nobuyuki Susumu</name></author><author><name sortKey="Aoki, Daisuke" sort="Aoki, Daisuke" uniqKey="Aoki D" first="Daisuke" last="Aoki">Daisuke Aoki</name></author><author><name sortKey="Konishi, Ikuo" sort="Konishi, Ikuo" uniqKey="Konishi I" first="Ikuo" last="Konishi">Ikuo Konishi</name></author><author><name sortKey="Covens, Alan" sort="Covens, Alan" uniqKey="Covens A" first="Alan" last="Covens">Alan Covens</name></author><author><name sortKey="Ledermann, Jonathan" sort="Ledermann, Jonathan" uniqKey="Ledermann J" first="Jonathan" last="Ledermann">Jonathan Ledermann</name></author><author><name sortKey="Mezzanzanica, Delia" sort="Mezzanzanica, Delia" uniqKey="Mezzanzanica D" first="Delia" last="Mezzanzanica">Delia Mezzanzanica</name></author><author><name sortKey="Mezzazanica, Delia" sort="Mezzazanica, Delia" uniqKey="Mezzazanica D" first="Delia" last="Mezzazanica">Delia Mezzazanica</name></author><author><name sortKey="Steer, Christopher" sort="Steer, Christopher" uniqKey="Steer C" first="Christopher" last="Steer">Christopher Steer</name></author><author><name sortKey="Millan, David" sort="Millan, David" uniqKey="Millan D" first="David" last="Millan">David Millan</name></author><author><name sortKey="Mcneish, Iain A" sort="Mcneish, Iain A" uniqKey="Mcneish I" first="Iain A" last="Mcneish">Iain A. Mcneish</name></author><author><name sortKey="Pfisterer, Jacobus" sort="Pfisterer, Jacobus" uniqKey="Pfisterer J" first="Jacobus" last="Pfisterer">Jacobus Pfisterer</name></author><author><name sortKey="Kang, Sokbom" sort="Kang, Sokbom" uniqKey="Kang S" first="Sokbom" last="Kang">Sokbom Kang</name></author><author><name sortKey="Gladieff, Laurence" sort="Gladieff, Laurence" uniqKey="Gladieff L" first="Laurence" last="Gladieff">Laurence Gladieff</name></author><author><name sortKey="Bryce, Jane" sort="Bryce, Jane" uniqKey="Bryce J" first="Jane" last="Bryce">Jane Bryce</name></author><author><name sortKey="Oza, Amit" sort="Oza, Amit" uniqKey="Oza A" first="Amit" last="Oza">Amit Oza</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25341576</idno><idno type="pmid">25341576</idno><idno type="doi">10.1097/IGC.0000000000000289</idno><idno type="wicri:Area/PubMed/Corpus">003342</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003342</idno><idno type="wicri:Area/PubMed/Curation">003231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003231</idno><idno type="wicri:Area/PubMed/Checkpoint">003231</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003231</idno><idno type="wicri:Area/Ncbi/Merge">001F27</idno><idno type="wicri:Area/Ncbi/Curation">001F27</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F27</idno><idno type="wicri:Area/Main/Merge">003915</idno><idno type="wicri:Area/Main/Curation">003880</idno><idno type="wicri:Area/Main/Exploration">003880</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.</title><author><name sortKey="Okamoto, Aikou" sort="Okamoto, Aikou" uniqKey="Okamoto A" first="Aikou" last="Okamoto">Aikou Okamoto</name><affiliation wicri:level="1"><nlm:affiliation>*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto</wicri:regionArea><wicri:noRegion>Toronto</wicri:noRegion></affiliation></author><author><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name></author><author><name sortKey="Mabuchi, Seiji" sort="Mabuchi, Seiji" uniqKey="Mabuchi S" first="Seiji" last="Mabuchi">Seiji Mabuchi</name></author><author><name sortKey="Matsumura, Noriomi" sort="Matsumura, Noriomi" uniqKey="Matsumura N" first="Noriomi" last="Matsumura">Noriomi Matsumura</name></author><author><name sortKey="Nomura, Hiroyuki" sort="Nomura, Hiroyuki" uniqKey="Nomura H" first="Hiroyuki" last="Nomura">Hiroyuki Nomura</name></author><author><name sortKey="Itamochi, Hiroaki" sort="Itamochi, Hiroaki" uniqKey="Itamochi H" first="Hiroaki" last="Itamochi">Hiroaki Itamochi</name></author><author><name sortKey="Takano, Masashi" sort="Takano, Masashi" uniqKey="Takano M" first="Masashi" last="Takano">Masashi Takano</name></author><author><name sortKey="Takano, Tadao" sort="Takano, Tadao" uniqKey="Takano T" first="Tadao" last="Takano">Tadao Takano</name></author><author><name sortKey="Susumu, Nobuyuki" sort="Susumu, Nobuyuki" uniqKey="Susumu N" first="Nobuyuki" last="Susumu">Nobuyuki Susumu</name></author><author><name sortKey="Aoki, Daisuke" sort="Aoki, Daisuke" uniqKey="Aoki D" first="Daisuke" last="Aoki">Daisuke Aoki</name></author><author><name sortKey="Konishi, Ikuo" sort="Konishi, Ikuo" uniqKey="Konishi I" first="Ikuo" last="Konishi">Ikuo Konishi</name></author><author><name sortKey="Covens, Alan" sort="Covens, Alan" uniqKey="Covens A" first="Alan" last="Covens">Alan Covens</name></author><author><name sortKey="Ledermann, Jonathan" sort="Ledermann, Jonathan" uniqKey="Ledermann J" first="Jonathan" last="Ledermann">Jonathan Ledermann</name></author><author><name sortKey="Mezzanzanica, Delia" sort="Mezzanzanica, Delia" uniqKey="Mezzanzanica D" first="Delia" last="Mezzanzanica">Delia Mezzanzanica</name></author><author><name sortKey="Mezzazanica, Delia" sort="Mezzazanica, Delia" uniqKey="Mezzazanica D" first="Delia" last="Mezzazanica">Delia Mezzazanica</name></author><author><name sortKey="Steer, Christopher" sort="Steer, Christopher" uniqKey="Steer C" first="Christopher" last="Steer">Christopher Steer</name></author><author><name sortKey="Millan, David" sort="Millan, David" uniqKey="Millan D" first="David" last="Millan">David Millan</name></author><author><name sortKey="Mcneish, Iain A" sort="Mcneish, Iain A" uniqKey="Mcneish I" first="Iain A" last="Mcneish">Iain A. Mcneish</name></author><author><name sortKey="Pfisterer, Jacobus" sort="Pfisterer, Jacobus" uniqKey="Pfisterer J" first="Jacobus" last="Pfisterer">Jacobus Pfisterer</name></author><author><name sortKey="Kang, Sokbom" sort="Kang, Sokbom" uniqKey="Kang S" first="Sokbom" last="Kang">Sokbom Kang</name></author><author><name sortKey="Gladieff, Laurence" sort="Gladieff, Laurence" uniqKey="Gladieff L" first="Laurence" last="Gladieff">Laurence Gladieff</name></author><author><name sortKey="Bryce, Jane" sort="Bryce, Jane" uniqKey="Bryce J" first="Jane" last="Bryce">Jane Bryce</name></author><author><name sortKey="Oza, Amit" sort="Oza, Amit" uniqKey="Oza A" first="Amit" last="Oza">Amit Oza</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma, Clear Cell (pathology)</term><term>Adenocarcinoma, Clear Cell (therapy)</term><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Ovarian Neoplasms (pathology)</term><term>Ovarian Neoplasms (therapy)</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adénocarcinome à cellules claires ()</term><term>Adénocarcinome à cellules claires (anatomopathologie)</term><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire ()</term><term>Tumeurs de l'ovaire (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome à cellules claires</term><term>Tumeurs de l'ovaire</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term><term>Ovarian Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term><term>Ovarian Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adénocarcinome à cellules claires</term><term>Association thérapeutique</term><term>Consensus</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer with a distinct clinical behavior. There are marked geographic differences in the prevalence of CCC. The CCC is more likely to be detected at an early stage than high-grade serous cancers, and when confined within the ovary, the prognosis is good. However, advanced disease is associated with a very poor prognosis and resistance to standard treatment. Cytoreductive surgery should be performed for patients with stage II, III, or IV disease. An international phase III study to compare irinotecan/cisplatin and paclitaxel/carboplatin as adjuvant chemotherapy for stage IIV CCC has completed enrollment (GCIG/JGOG3017). Considering the frequent PIK3CA mutation in CCC, dual inhibitors targeting PI3K, AKT in the mTOR pathway, are promising. Performing these trials and generating the evidence will require considerable international collaboration.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Aoki, Daisuke" sort="Aoki, Daisuke" uniqKey="Aoki D" first="Daisuke" last="Aoki">Daisuke Aoki</name><name sortKey="Bryce, Jane" sort="Bryce, Jane" uniqKey="Bryce J" first="Jane" last="Bryce">Jane Bryce</name><name sortKey="Covens, Alan" sort="Covens, Alan" uniqKey="Covens A" first="Alan" last="Covens">Alan Covens</name><name sortKey="Gladieff, Laurence" sort="Gladieff, Laurence" uniqKey="Gladieff L" first="Laurence" last="Gladieff">Laurence Gladieff</name><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name><name sortKey="Itamochi, Hiroaki" sort="Itamochi, Hiroaki" uniqKey="Itamochi H" first="Hiroaki" last="Itamochi">Hiroaki Itamochi</name><name sortKey="Kang, Sokbom" sort="Kang, Sokbom" uniqKey="Kang S" first="Sokbom" last="Kang">Sokbom Kang</name><name sortKey="Konishi, Ikuo" sort="Konishi, Ikuo" uniqKey="Konishi I" first="Ikuo" last="Konishi">Ikuo Konishi</name><name sortKey="Ledermann, Jonathan" sort="Ledermann, Jonathan" uniqKey="Ledermann J" first="Jonathan" last="Ledermann">Jonathan Ledermann</name><name sortKey="Mabuchi, Seiji" sort="Mabuchi, Seiji" uniqKey="Mabuchi S" first="Seiji" last="Mabuchi">Seiji Mabuchi</name><name sortKey="Matsumura, Noriomi" sort="Matsumura, Noriomi" uniqKey="Matsumura N" first="Noriomi" last="Matsumura">Noriomi Matsumura</name><name sortKey="Mcneish, Iain A" sort="Mcneish, Iain A" uniqKey="Mcneish I" first="Iain A" last="Mcneish">Iain A. Mcneish</name><name sortKey="Mezzanzanica, Delia" sort="Mezzanzanica, Delia" uniqKey="Mezzanzanica D" first="Delia" last="Mezzanzanica">Delia Mezzanzanica</name><name sortKey="Mezzazanica, Delia" sort="Mezzazanica, Delia" uniqKey="Mezzazanica D" first="Delia" last="Mezzazanica">Delia Mezzazanica</name><name sortKey="Millan, David" sort="Millan, David" uniqKey="Millan D" first="David" last="Millan">David Millan</name><name sortKey="Nomura, Hiroyuki" sort="Nomura, Hiroyuki" uniqKey="Nomura H" first="Hiroyuki" last="Nomura">Hiroyuki Nomura</name><name sortKey="Oza, Amit" sort="Oza, Amit" uniqKey="Oza A" first="Amit" last="Oza">Amit Oza</name><name sortKey="Pfisterer, Jacobus" sort="Pfisterer, Jacobus" uniqKey="Pfisterer J" first="Jacobus" last="Pfisterer">Jacobus Pfisterer</name><name sortKey="Steer, Christopher" sort="Steer, Christopher" uniqKey="Steer C" first="Christopher" last="Steer">Christopher Steer</name><name sortKey="Susumu, Nobuyuki" sort="Susumu, Nobuyuki" uniqKey="Susumu N" first="Nobuyuki" last="Susumu">Nobuyuki Susumu</name><name sortKey="Takano, Masashi" sort="Takano, Masashi" uniqKey="Takano M" first="Masashi" last="Takano">Masashi Takano</name><name sortKey="Takano, Tadao" sort="Takano, Tadao" uniqKey="Takano T" first="Tadao" last="Takano">Tadao Takano</name></noCountry><country name="Canada"><noRegion><name sortKey="Okamoto, Aikou" sort="Okamoto, Aikou" uniqKey="Okamoto A" first="Aikou" last="Okamoto">Aikou Okamoto</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003880 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003880 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25341576
|texte= Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25341576" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |